Cargando…

Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic

Detalles Bibliográficos
Autores principales: Zhu, Jing, Rao, Gauri, Armistead, Paul M., Ptachcinski, Jonathan, Weiner, Daniel L., Wiltshire, Tim, Crona, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652756/
https://www.ncbi.nlm.nih.gov/pubmed/34743423
http://dx.doi.org/10.1111/cts.13177
_version_ 1784611612061073408
author Zhu, Jing
Rao, Gauri
Armistead, Paul M.
Ptachcinski, Jonathan
Weiner, Daniel L.
Wiltshire, Tim
Crona, Daniel J.
author_facet Zhu, Jing
Rao, Gauri
Armistead, Paul M.
Ptachcinski, Jonathan
Weiner, Daniel L.
Wiltshire, Tim
Crona, Daniel J.
author_sort Zhu, Jing
collection PubMed
description
format Online
Article
Text
id pubmed-8652756
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86527562021-12-08 Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic Zhu, Jing Rao, Gauri Armistead, Paul M. Ptachcinski, Jonathan Weiner, Daniel L. Wiltshire, Tim Crona, Daniel J. Clin Transl Sci Perspectives John Wiley and Sons Inc. 2021-11-07 2022-03 /pmc/articles/PMC8652756/ /pubmed/34743423 http://dx.doi.org/10.1111/cts.13177 Text en © 2021 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Perspectives
Zhu, Jing
Rao, Gauri
Armistead, Paul M.
Ptachcinski, Jonathan
Weiner, Daniel L.
Wiltshire, Tim
Crona, Daniel J.
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
title Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
title_full Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
title_fullStr Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
title_full_unstemmed Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
title_short Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
title_sort insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the covid‐19 pandemic
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652756/
https://www.ncbi.nlm.nih.gov/pubmed/34743423
http://dx.doi.org/10.1111/cts.13177
work_keys_str_mv AT zhujing insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic
AT raogauri insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic
AT armisteadpaulm insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic
AT ptachcinskijonathan insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic
AT weinerdaniell insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic
AT wiltshiretim insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic
AT cronadanielj insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic